scispace - formally typeset
M

Morihiro Iwata

Researcher at Toho University

Publications -  24
Citations -  455

Morihiro Iwata is an academic researcher from Toho University. The author has contributed to research in topics: Carbapenem & Meropenem. The author has an hindex of 14, co-authored 24 publications receiving 426 citations.

Papers
More filters
Journal ArticleDOI

Isolation of Helicobacter cinaedi from blood of an immunocompromised patient in Japan.

TL;DR: H. cinaedi bacteremia should be considered as one of the critical infectious diseases in immunocompromised patients, and the sequencing of 16S rRNA may be a useful method to confirm the identification of this organism.
Journal ArticleDOI

Primary Shewanella alga septicemia in a patient on hemodialysis.

TL;DR: Although the role of S. alga as a human pathogen has not been fully determined, accumulating data suggest that this organism may be a potential pathogen, especially in compromised hosts.
Journal Article

In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,866 clinical isolates obtained from 72 centers in 2010

TL;DR: The present survey was performed to investigate in vitro susceptibility of recent clinical isolates in Japan to 30 selected antibacterial agents, focusing on fluoroquinolones (FQs), and indicated that although methicillin-resistant staphylococci, Enterococcus faecium, P. aeruginosa from UTIs, N. gonorrhoeae, and E. coli showed high susceptibility to FQs, this trend was consistent with the results of previous surveillance.
Journal ArticleDOI

Identification of VanB-Type Vancomycin Resistance in Enterococcus gallinarum from Japan.

TL;DR: In late January 1996, pus obtained from a periproctal abscess on an acute myeloid leukemia patient in Toho University Omori Hospital yieldedEnterococcus gallinarum strain TUH327, which appears to be the first reported isolation anywhere in the world of motile enterococci harboringvanB, and also the first report ofvanB in any enteringococci from Japan.
Journal ArticleDOI

Evaluation of new medium with chromogenic substrates for members of the family Enterobacteriaceae in urine samples.

TL;DR: A new medium containing 5-bromo-4-chloro-3-indolyl-beta-D-glucuronide cyclohexylammonium salt (Glu agar) for Escherichia coli and a new medium for beta-galactosidase-positive members of the family Enterobacteriaceae were compared with MacConkey agar in a diagnostic trial with 3,562 urine specimens.